Experimental tumors and aging: local factors that may account for the observed age advantage in the B16 murine melanoma model

Exp Gerontol. 1984;19(6):367-76. doi: 10.1016/0531-5565(84)90046-9.

Abstract

In the B16 murine melanoma model tumor growth has been shown to be slower in animals of advanced age. One feature associated with this slower growth has been prominent fibrosis demonstrated in biopsies of the tumor in older animals. We have performed experiments to examine the fibrotic response in young and old mice. In non-tumor bearing animals the capacity to regain skin strength after surgical laceration and healing by primary intention was greater in old mice. Histologic preparations suggested a more prominent fibrosis at the wound site. The animals who were injected subcutaneously with B16 melanoma and treated with L 3,4-dehydroproline (an inhibitor of collagen synthesis) local tumor growth was significantly enhanced only for the old animals. Although this inhibition of collagen synthesis produced a differential growth enhancement, there remained a significant difference in tumor volume between young and old animals. We conclude that fibrogenesis is an important host defense for containing local tumor growth and that this mechanism is preserved if not enhanced in mice of advanced age. Nevertheless other factors are needed to account completely for the observed age-advantage in the B16 melanoma model.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aging*
  • Animals
  • Collagen / biosynthesis
  • Male
  • Melanoma / pathology*
  • Mice
  • Mice, Inbred C57BL
  • Proline / analogs & derivatives
  • Proline / pharmacology
  • Wound Healing

Substances

  • 3,4-dehydroproline
  • Collagen
  • Proline